Proteolysis Targeting Chimera Research Reagents (905)

PROTACs are composed of a small molecule ligand that targets a specific protein and facilitates its interaction with an E3 ubiquitin ligase, leading to the protein's ubiquitination and subsequent degradation by the proteasome system. These tools are employed to investigate protein function, identify potential drug targets, and create innovative therapeutic approaches for conditions like cancer and neurodegenerative diseases.